Mahamaya Lifesciences Ltd.
185.35+2.3 (+1.28%)
9 Sep, 12:00 AM
Analyst Ratings and Targets
Mahamaya Lifesciences Ltd. analyst ratings, buy/sell/hold recommendations and 12-month price targets from leading brokerages.
Analyst Ratings
Seems like this stock doesn't have any active recommendations by analyst.
Target Price
Seems like this stock doesn't have any active target price estimates by analyst.
Financial Estimates
Mahamaya Lifesciences Ltd. analyst consensus estimates for revenue, EBITDA, PAT and EPS (consolidated) for the next 2 financial years on a rolling basis.
This stock doesn't have any active financial estimates by analysts, or consolidated estimates are not available.
Estimates Revision
How Mahamaya Lifesciences Ltd. analyst consensus for revenue and earnings has been revised over the last 12 months.
This stock doesn't have any active financial estimates by analysts, or consolidated estimates are not available.
Frequently Asked Questions
What is the analyst consensus recommendation for Mahamaya Lifesciences Ltd.?
The analyst consensus recommendation for Mahamaya Lifesciences Ltd. can be found in the Analyst Ratings section. It aggregates buy, hold and sell ratings from brokerages covering the stock.
What is the target price for Mahamaya Lifesciences Ltd.?
The median analyst target price for Mahamaya Lifesciences Ltd. is shown in the Analyst Ratings section, along with the highest and lowest targets from all covering analysts.
How many analysts cover Mahamaya Lifesciences Ltd.?
The number of analysts actively covering Mahamaya Lifesciences Ltd. is displayed in the Analyst Ratings section of the Forecast tab, including their buy, hold and sell breakdown.
What is the upside or downside potential for Mahamaya Lifesciences Ltd. from the current price?
The upside potential is calculated as the percentage difference between the median analyst target price and the current market price of ₹ 185.35. Refer to the Analyst Ratings section for the latest target.
What is the revenue estimate for Mahamaya Lifesciences Ltd. for the next financial year?
Analyst consensus revenue estimates for Mahamaya Lifesciences Ltd. for the next one to two financial years are available in the Financial Estimates section of the Forecast tab.
What is the EPS estimate for Mahamaya Lifesciences Ltd.?
The current trailing twelve month EPS of Mahamaya Lifesciences Ltd. is 8.33. Forward EPS estimates from analyst consensus are available in the Financial Estimates section.
What is the BPS estimate for Mahamaya Lifesciences Ltd.?
Book Value Per Share (BPS) estimates for Mahamaya Lifesciences Ltd. from analyst consensus are available in the Financial Estimates section of the Forecast tab. BPS reflects the net asset value per share and is used to gauge price-to-book valuation.
Are analysts bullish or bearish on Mahamaya Lifesciences Ltd.?
Analyst sentiment on Mahamaya Lifesciences Ltd. is reflected through the buy/hold/sell distribution shown in the Analyst Ratings section. The consensus outlook is updated as brokerages revise their ratings.
Has the analyst consensus for Mahamaya Lifesciences Ltd. been revised recently?
Estimate revision history for Mahamaya Lifesciences Ltd. is available in the Estimates Revision section of the Forecast tab, showing how analyst consensus for revenue and earnings has changed over the past 12 months.
What is the current PE ratio of Mahamaya Lifesciences Ltd. compared to the target implied PE?
The current trailing PE of Mahamaya Lifesciences Ltd. is 26.25. The target-implied PE can be calculated using the analyst median price target and current EPS. See the Analyst Ratings section for the latest target prices.